论文部分内容阅读
目的:观察脑心通胶囊对肥胖原发性高血压患者血清瘦素的影响。方法:将120例肥胖原发高血压随机分为观察组和对照组各60例,对照组采用左旋氨氯地平治疗,观察组在对照组治疗基础上加服脑心通胶囊,12周后观察两组血清瘦素水平。结果:治疗后观察组与对照组血清瘦素水平分别为(8.50±3.76)和(14.32±6.26),两组比较差异非常显著(P<0.01)。结论:脑心通胶囊能显著降低肥胖原发性高血压患者血清瘦素水平。
Objective: To observe the effects of Naoxintong capsule on serum leptin in obese patients with essential hypertension. Methods: 120 cases of obese essential hypertension were randomly divided into observation group and control group, 60 cases in each group. The control group was treated with levamlodipine. The observation group was treated with Naoxintong capsule on the basis of the control group. After 12 weeks, Serum leptin levels in both groups. Results: After treatment, the serum leptin levels of the observation group and the control group were (8.50 ± 3.76) and (14.32 ± 6.26) respectively, with significant difference between the two groups (P <0.01). Conclusion: Naoxintong capsule can significantly reduce the level of serum leptin in patients with obesity and essential hypertension.